---
layout: splash
title: 한올바이오파마 (009420)
excerpt: 한올바이오파마의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
- 고PER
- 고PBR
keywords: 한올바이오파마, 009420
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 37,000 | <span style="color: cornflowerblue">-3.3<small>%</small></span> | P:의약품 | 536.2 | 10.1 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 의약품 제조, 도매/부동산 임대 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 1989년 12월 18일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 정승원,박수진(공동대표이사) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.hanall.co.kr](http://www.hanall.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 07&#x2011;25 | | [주요사항보고서(자기주식처분결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240725000295){:target="_blank"} |
|  | | [연결재무제표기준영업(잠정)실적(공정공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240725800397){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![009420](/stock/images/009420.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 37,000 | <span style="color: cornflowerblue">-3.3<small>%</small></span> | <span style="color: tomato">2.8<small>%</small></span> | <span style="color: tomato">20.3<small>%</small></span> | <span style="color: tomato">6.5<small>%</small></span> | <span style="color: tomato">12.6<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">68.0<small>%</small></span> | 67.1<small>%</small> | 1.01 | -34.8<small>%</small> | -15.4<small>%</small> | -2.0 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 536.2 | 10.1 | - | 고PER, 고PBR |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/009420/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=009420){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A009420&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=009420){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/009420){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/009420/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![009420](/stock/images/009420_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 68.0<small>%</small> | 67.1<small>%</small> | 1.01 | -34.8<small>%</small> | -15.4<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 14.9<small>%</small> | 66.0<small>%</small> | 0.23 | -39.3<small>%</small> | -21.6<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 48.6<small>%</small> | 42.0<small>%</small> | 1.16 | -19.3<small>%</small> | -7.7<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -11.4<small>%</small> | 47.7<small>%</small> | -0.24 | -35.6<small>%</small> | -12.9<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -17.1<small>%</small> | 56.8<small>%</small> | -0.30 | -49.5<small>%</small> | -26.2<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 7.6<small>%</small> | 59.0<small>%</small> | 0.13 | -48.0<small>%</small> | -21.5<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 12.0<small>%</small> | 60.7<small>%</small> | 0.20 | -45.9<small>%</small> | -20.8<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 54.7<small>%</small> | 66.1<small>%</small> | 0.83 | -34.8<small>%</small> | -15.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | -10.4<small>%</small> | 45.3<small>%</small> | -0.23 | -32.7<small>%</small> | -15.7<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![009420](/stock/images/009420_corr.png){: .align-center}

|       | [종근당](/185750/) | [대웅제약](/069620/) | [녹십자홀딩스](/005250/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [대웅](/003090/) | [한미약품](/128940/) | [유티아이](/179900/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![009420](/stock/images/009420_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info} [고PER 목록](/fn/fn_high_per/){: .btn .btn--info} [고PBR 목록](/fn/fn_high_pbr/){: .btn .btn--info}

{% include commons/footnotes.md %}